Computational Biology Market - Size, Share, Outlook, and Opportunity Analysis, 2019

Computational Biology are used of data-analytical and theoretical methods, mathematical modeling and computational simulation techniques in life sciences. Predictive modeling tools provide vital information for better streamlining of drug development process thus reducing time and increasing efficiency. Increasing use of bioinformatics tools along with increasing investment in research and development is expected to propel the market growth during the forecast period. Furthermore, increasing patient population suffering from chronic diseases, increasing adoption of cloud computing for data storage is also anticipated to assist the growth of the market during the forecast period.

Key features of the study:

This report provides in-depth analysis of the Global Computational Biology market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020–2027), considering 2019 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the Global Computational Biology market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Accelrys, Certara, L.P., Chemical Computing Group Inc., Compugen, Ltd., Entelos, Inc. (Rosa & Co. LLC), Genedata AG, Insilico Biotechnology AG, Leadscope, Inc., Nimbus Discovery LLC, Rhenovia Pharma SAS, Schrodinger, and Simulation Plus, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The Global Computational Biology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Computational Biology market

Detailed Segmentation:

Global Computational Biology Market, By Type:

Cellular & Biological Simulation
Computational Genomics
Computational Proteomics
Pharmacogenomics
Others (Transcriptomics/Metabolomic)
Disease Modeling and Simulation Applications
Drug Discovery
Drug Development
Global Computational Biology Market, By Tools
Content/Database
Analysis Software & Services
IT Infrastructure (Hardware)

Global Computational Biology Market, By Region:

North America
By Country
U.S.
Canada
Latin America
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Country
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Country
GCC
Israel
Rest of Middle East
Africa
By Country/Region
South Africa
Central Africa
North Africa

Company Profiles

Accelrys *
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Certara, L.P.
Chemical Computing Group Inc.
Compugen, ltd.
Entelos, Inc. (Rosa & Co. LLC)
Genedata AG
Insilico Biotechnology AG
Leadscope, Inc.
Nimbus Discovery LLC
Rhenovia Pharma SAS
Schrodinger
Simulation Plus, Inc.
“*” marked represents similar segmentation in other categories in the respective section.